Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

The FDA has started a priority review of BeOne Medicines' BCL2 inhibitor sonrotoclax in relapsed or refractory mantle cell ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for ...

The NHS’s Online Hospital ambition signals intent. But to make it real, the focus must move from building a digital replica ...

YourCoach Health’s Eugene and Marina Borukhovich spoke with pharmaphorum after their Frontiers Health session to get to the ...

Novo Nordisk said it will now move ahead with a phase 3 programme for both versions of the drug in adults with type 2 ...

UK researchers have developed a platform that can test whether commercial AI algorithms developed for NHS applications are ...

Direct-to-Patient (DTP) platforms represent a new frontier in patient support services. Properly executed, they help more ...

Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...